Ocular Therapeutix (OCUL) Return on Equity [ROE] (2014 - 2026)
Ocular Therapeutix's Return on Equity [ROE] was -54.96% in Q2 2026, up 22.98 percentage points from -77.94% a year earlier but down 7.95 percentage points from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Ocular Therapeutix came in at -54.35%, up 26.87 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +137.32 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -81.22% in FY2024 (+60.64 pp), -141.87% in FY2023 (-4.28 pp), -137.59% in FY2022 (-34.39 pp) and -103.20% in FY2021 (+88.47 pp).
- Quarterly Return on Equity [ROE] has moved between -1604.75% (Q3 2023) and -29.70% (Q2 2024) over five years.
- Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of +200.94 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 12444.69 percentage points); the worst was Q3 2023 (a drop of 1455.12 percentage points).
- Per Business Quant data, OCUL's Return on Equity [ROE] in the three quarters before Q2 2026 was -47.01% (Q1 2026), -57.75% (Q4 2025) and -87.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | -54.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.96% |
| Mar 31, 2026 | -47.01% |
| Dec 31, 2025 | -57.75% |
| Sep 30, 2025 | -87.66% |
| Jun 30, 2025 | -77.94% |
| Mar 31, 2025 | -67.58% |
| Dec 31, 2024 | -49.47% |
| Sep 30, 2024 | -38.04% |
| Jun 30, 2024 | -29.70% |
| Mar 31, 2024 | -39.16% |
| Dec 31, 2023 | -181.32% |
| Sep 30, 2023 | -1,604.75% |
| Jun 30, 2023 | -1,397.22% |
| Mar 31, 2023 | -395.36% |
| Dec 31, 2022 | -208.01% |
| Sep 30, 2022 | -149.63% |
| Jun 30, 2022 | -112.56% |
| Mar 31, 2022 | -98.07% |
| Dec 31, 2021 | -96.59% |
| Sep 30, 2021 | -96.69% |
API Access
Ocular Therapeutix Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();